In the SURMOUNT5 trial, participants lost an average of 20.2 % of their baseline body weight over 72 weeks with tirzepatide, with a greater proportion achieving weight-loss thresholds of 1525 % compared with semaglutide
Clinician check-ins included
This means the microbiome may strengthen or weaken the drugs effects, depending on which bacteria are present
However, pairing GLP-1 supplementation with the right lifestyle changes may support better appetite control and consistency
They all become slim, said Madesh Muniswamy, PhD, a professor of medicine at the Joe R
By discussing any occurrences of dizziness, patients contribute valuable information that can inform treatment adjustments and management strategies